Access cutting-edge neuroblastoma treatment through this clinical trial at a research site in Oakland. Study-provided care at no cost to qualified participants.
Access neuroblastoma specialists in Oakland at no cost
This study follows strict safety protocols and ethical guidelines
All study-related neuroblastoma treatment provided free
This is a prospective, multicenter clinical trial in subjects with newly diagnosed high-risk neuroblastoma to evaluate the efficacy and safety of administering naxitamab with standard induction therapy. The initial chemotherapy will include 5 cycles of multi-agent chemotherapy. Naxitamab will be added to all 5 Induction cycles. We hypothesize that the addition of anti-GD2 therapy to induction chemotherapy will result in improved end of induction responses and improved survival.
Sponsor: Giselle Sholler
Check if you qualify for this neuroblastoma clinical trial in Oakland, CA
If you're searching for neuroblastoma treatment options in Oakland, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Oakland research site is actively enrolling participants for this clinical trial. You'll receive care from experienced neuroblastoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.